tranexamic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardson, SG | 1 |
| Clarke, CW | 1 |
| Gasson, GB | 1 |
1 other study available for tranexamic acid and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Lymphocytic lymphoma and acquired C1 esterase inhibitor deficiency.
Topics: Angioedema; Complement C1 Inactivator Proteins; Complement C3; Complement C4; Female; Humans; Leukem | 1989 |